Indrayani Biotech Limited (BOM:526445)
India · Delayed Price · Currency is INR 7.94
-0.04 (-0.50%)
At close: Aug 28, 2026
Indrayani Biotech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,378 | 1,378 | 1,302 | 1,662 | 1,629 | 615.82 |
Revenue Growth | 3.36% | 5.84% | -21.66% | 2.02% | 164.57% | 190.60% |
Gross Profit Gross Profit Growth | 437.58 | 437.58 | 456.61 | 672.98 | 590.2 | 201.72 |
Operating Income Operating Income Growth | 99.01 | 99.01 | 53.64 | 206.58 | 146.79 | 62.17 |
Net Income Net Income Growth | 3.7 | 3.7 | -15.57 | 63.65 | 87.37 | 43.93 |
Earnings Per Share EPS Growth | 0.08 | 0.08 | -0.35 | 1.40 | 2.01 | 1.28 |
EPS Growth | - | - | - | -30.35% | 57.03% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Engineering Division Engineering Division Growth | 1.08 | 9.65 | 15.07 | 10.07 |
Food Catering Food Catering Growth | 411.77 | 609.98 | 726.62 | 572.02 |
Milk & Associated Products Milk & Associated Products Growth | 713.41 | 855.58 | 827.21 | - |
Health Care Services Health Care Services Growth | 102.74 | 66.34 | 27.84 | 35.38 |
Unallocated Unallocated Growth | 154.93 | 434.87 | 77.41 | 0.45 |
Inter Segment Sales Inter Segment Sales Growth | -50.39 | -302.02 | - | - |
Total Total Growth | 1,334 | 1,674 | 1,674 | 617.93 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 42.56 | 42.56 | 265 | 302.52 | 126.94 | 21.8 |
Total Debt Total Debt Growth | 1,283 | 1,283 | 1,371 | 1,125 | 701.86 | 187.94 |
Net Cash (Debt) Net Cash Growth | -1,240 | -1,240 | -1,106 | -822.72 | -574.92 | -166.15 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -27.27 | -27.27 | -24.28 | -18.07 | -13.22 | -4.85 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 316.54 | 316.54 | -67.42 | -303.54 | 161.88 | 41.11 |
Capital Expenditures CapEx Growth | -151.92 | -151.92 | -13.76 | -163.02 | -215.28 | -11.89 |
Free Cash Flow Free Cash Flow Growth | 164.62 | 164.62 | -81.17 | -466.56 | -53.4 | 29.22 |
Free Cash Flow Growth | 77.90% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 31.75% | 31.75% | 35.06% | 40.49% | 36.22% | 32.76% |
Operating Margin | 7.18% | 7.18% | 4.12% | 12.43% | 9.01% | 10.10% |
Pretax Margin | 0.22% | 0.22% | -4.41% | 6.60% | 7.55% | 7.23% |
Profit Margin | 0.27% | 0.27% | -1.20% | 3.83% | 5.36% | 7.13% |
FCF Margin | 11.94% | 11.94% | -6.23% | -28.07% | -3.28% | 4.75% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 97.53 | 88.91 | - | 35.18 | 22.14 | 23.76 |
P/FCF Ratio | 2.20 | 2.00 | - | - | - | 35.73 |
PS Ratio | 0.26 | 0.24 | 0.50 | 1.35 | 1.19 | 1.70 |